Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.1050
-0.0050 (-4.55%)
Oct 30, 2026, 9:30 AM EDT
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of CAD 14.47 million as of October 30, 2026. It is the 41,189th most valuable company in the world and the 1,412th biggest in Canada. Its market cap has decreased by 32.25% in one year.
Market Cap
14.47M
Enterprise Value
20.26M
Revenue
2.58M
Global Rank
Country Rank
#1,412 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 63.77M to 14.47M, a decrease of -77.31%. That is a compound annual growth rate of -17.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 14.47M | -18.04% |
| Dec 31, 2025 | 17.65M | -37.53% |
| Dec 31, 2024 | 28.26M | 63.18% |
| Dec 29, 2023 | 17.32M | -67.57% |
| Dec 31, 2021 | 53.40M | 110.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telescope Innovations | 24.65M |
| The More Life Company | 22.85M |
| Devonian Health Group | 21.52M |
| Pharmala Biotech Holdings | 18.65M |
| Onco-Innovations | 15.92M |
| Lobe Sciences | 15.28M |
| Alzai Health | 12.96M |
| PreveCeutical Medical | 12.76M |